Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Muscle Derived Cells for Underactive Bladder
NCT02463448Phase 1Completed
- Start
- Nov 2016
- Primary completion
- Dec 2019
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of AMDC-USR in underactive bladder (UAB). Primary endpoint: Number of Participants With Study-related Adverse Events at 6 months. Started Nov 2016; status: completed.
02
Drugs
AMDC-USR
03
Conditions
underactive bladder (UAB)
Beyond the preview
Go deeper on NCT02463448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02463448.